AnalystBook Research · Company Intelligence

Claros Mortgage Trust, Inc.

CMTGNYSE

Built from Claros Mortgage Trust, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Claros Mortgage cut debt and dividends, but the loss widened sharply.

The read at a glance✓ Audited against SEC data
  • Business mixTransitional CRE lenderNote
  • Revenue$187.8M, -24.4%Watch
  • Net loss$489.1M, widerWatch
  • OCF($30.5M), from inflowWatch
  • Debt$3.16B, -35.6%OK
  • Insiders3 purchases / 0 salesOK

Business

Claros Mortgage Trust is a CRE finance company focused on senior and subordinate loans on transitional commercial real estate assets.

Where the revenue comes from

Fiscal 2025, as Claros Mortgage Trust, Inc. reports it. History and quarterly detail are in the app.

  • CMTGTT$1K

Leadership changes

From Claros Mortgage Trust, Inc.'s own filings, the day they're filed.

  • Andrew Silberstein · Directors · appointmenteff. 2026-05-11
  • Almanac Realty Investors · director · appointmenteff. 2026-05-11
  • Designation Right · director · departureeff. 2026-05-11

Latest filings

  • 10-Q · Quarterly report2026-07-29
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-06-05
  • 8-K · Company announcement2026-05-12
  • 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Claros Mortgage Trust, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.